The dosage information for drugs used in HIV treatment, malaria, cancer care, pain management and transplantation is largely ...

A new statistical framework could speed up the search for rare mutations that cause common diseases, helping researchers zero ...

A UCLA study has outlined a new framework that researchers say would improve the predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well ...

The openSNP project, a platform for sharing genetic and phenotypic data, will shut down on April 30, 2025, and delete all user submissions over privacy concerns and the risk of misuse by authoritarian ...

23andMe has officially filed for Chapter 11 bankruptcy protection, which means a new company could acquire its genetic database. DNA data is particularly sensitive, and bad actors can use it to carry ...

Forbes contributors publish independent expert analyses and insights. Digital forensics, AI, deepfakes, and what becomes proof in court. Regeneron Pharmaceuticals announced on Monday it will acquire ...

DNA and genetic testing firm 23andMe is in turmoil following a 2023 data breach and its ongoing financial decline. The once-pioneering giant now faces an uncertain future as bankruptcy looms over the ...

Well before the term “personalized medicine” first appeared, the notion of healthcare tailored to the individual loomed on ...

Growing up in a society with a wide gap between the rich and the poor is linked to higher rates of depressive symptoms later ...

A Neanderthal skull from Forbes' Quarry, Gibraltar. (AquilaGib/Wikimedia Commons, CC BY-SA 3.0) Genetic deterioration may not ...

Any new owner of 23AndMe’s data will want to find ways to make money from it. Lawmakers have a big opportunity to help keep it safe Stop me if you’ve heard this one before: A tech company accumulates ...